{
    "ticker": "LONZ",
    "name": "Lonza Group AG",
    "description": "Lonza Group AG is a Swiss multinational company and a leading supplier to the pharmaceutical, biotech, and specialty ingredients markets. Founded in 1897, Lonza has established itself as a pivotal player in the life sciences sector, providing a wide range of services and products that span the entire drug development and manufacturing process. The company specializes in the development and production of active pharmaceutical ingredients (APIs), as well as offering tailored services for biologics and cell and gene therapies. Lonza\u2019s state-of-the-art facilities and commitment to quality enable it to meet the stringent regulatory requirements of the healthcare industry. In addition to its pharmaceutical services, Lonza is also involved in consumer products, providing solutions for the personal care, food, and agricultural industries. With a strong focus on sustainability and innovation, Lonza is committed to advancing science and improving the quality of life for people around the globe. The company operates globally, with facilities across Europe, North America, and Asia, providing unparalleled expertise and support to its clients in navigating the complexities of drug development and market entry.",
    "industry": [
        "Pharmaceuticals",
        "Biotechnology",
        "Specialty Ingredients"
    ],
    "headquarters": "Basel, Switzerland",
    "founded": "1897",
    "website": "https://www.lonza.com",
    "ceo": "Albert Baehny",
    "social_media": {
        "twitter": "https://twitter.com/lonza_group",
        "linkedin": "https://www.linkedin.com/company/lonza/"
    },
    "investor_relations": "https://www.lonza.com/investors",
    "key_executives": [
        {
            "name": "Albert Baehny",
            "position": "CEO"
        },
        {
            "name": "Max B. B\u00e4rtsch",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pharmaceuticals",
            "products": [
                "Active Pharmaceutical Ingredients",
                "Biologics Manufacturing"
            ]
        },
        {
            "category": "Specialty Ingredients",
            "products": [
                "Personal Care Solutions",
                "Food Ingredients"
            ]
        }
    ],
    "seo": {
        "meta_title": "Lonza Group AG | Pharmaceutical and Biotechnology Solutions",
        "meta_description": "Explore Lonza Group AG, a leader in pharmaceutical and biotechnology services. Learn about Lonza's innovative solutions and commitment to quality in drug development.",
        "keywords": [
            "Lonza",
            "Pharmaceuticals",
            "Biotechnology",
            "Active Pharmaceutical Ingredients",
            "Biologics",
            "Cell and Gene Therapies"
        ]
    },
    "faq": [
        {
            "question": "What is Lonza known for?",
            "answer": "Lonza is known for its services in pharmaceutical development and manufacturing, particularly in active pharmaceutical ingredients and biologics."
        },
        {
            "question": "Who is the CEO of Lonza?",
            "answer": "Albert Baehny is the CEO of Lonza Group AG."
        },
        {
            "question": "Where is Lonza headquartered?",
            "answer": "Lonza is headquartered in Basel, Switzerland."
        },
        {
            "question": "What are Lonza's main product categories?",
            "answer": "Lonza's main product categories include pharmaceuticals and specialty ingredients."
        },
        {
            "question": "When was Lonza founded?",
            "answer": "Lonza was founded in 1897."
        }
    ],
    "competitors": [
        "PFE",
        "ABBV",
        "BMY",
        "MCK"
    ],
    "related_stocks": [
        "JNJ",
        "GILD",
        "AMGN",
        "MRNA"
    ]
}